Abstract:Objective To evaluate the efficacy and safety of beclometasone dipropionate aqueous nasal spray in the treatment of allergic rhinitis.Methods This is a multieenter,randomized,doubleblind,and positive drug parallel controlled clinical trial.The patients with allergic rhinitis and who met the eligibility criteria were enrolled and divided into the test group and the control group.The patients in the test group received beclometasone dipropionate aqueous nasal spray and the patients in the control group received beclometasone dipropionate nasal spray.All patients in the 2 groups were administered two inhalations of beclomethasone dipropionate into each nostril twice daily(each inhalation contains beclometasone dipropionate 50 μg) for 14 days.The efficacy of these two drugs was evaluated according to the total scores of symptoms of rhinitis,scores of signs and quality of life and percentage changes of patients in three scores mentioned above when the treatment was over.The safety of these two drugs was evaluated according to the incidence of adverse events/adverse reactions,the results of laboratory tests,and ECG when the treatment was over.Results A total of 239 patients were included into the efficacy analysis.Of them,120 patients were in the test group and 119 were in the control group.There was no significant differences in gender, age,rhinitis symptoms,and signs before the drug administration between the 2 groups(P>0.05).The total scores of symptoms of rhinitis,scores of signs and quality of life on days 7 and 14 of treatment decreased significantly as compared with those obtained before the treatment in the both groups(P<0.05), but there was no significant difference in the extent of decrease between the 2 groups(P>0.05).When the treatments were over,the differences in the percentage changes of patients of rhinitis symptoms,signs and quality of life scores before and after treatments in the both 2 groups were statistically significant(P< 0.05),but there was no significant difference between the 2 groups(P>0.05).A total of 241 patients were included into the safety analysis.Of them,121 patients were in the test group and 120 were in the control group.There were 12 adverse events in 10 patients in the test group.Of them,2 events in the 2 patients were adverse drug reactions,including 1 case with throat discomfort and another case with nose bleeding.There were 20 adverse events in the 13 patients in the control group.Of them,11 events in 7 patients were adverse drug reactions and nose bleeding and dry nose were their major manifestations.There was no significant difference in the incidence of adverse events between the 2 groups(P>0.05).No severe adverse events occurred during the clinical trial.Conclusion Beclometasone dipropionate aqueous nasal spray could effectively control the symptoms of allergic rhinitis and its efficacy and safety were similar to those of beclometasone dipropionate nasal spray.

Efficacy of Loratadine Combined with Budesonide Nasal Spray in the Treatment of Allergic Rhinitis and its Effect on Th1/Th2 Cytokines

Effect of Loratadine Tablets in Combination with Other Drugs on Nasal Physiological Function and T Lymphocyte Subsets in Patients with Allergic Rhinitis

Effect of Loratadine and Budesonide on Asthmatic Patients with Allergic Rhinitis

Randomized Controlled Clinical Trial Comparing Budesonide Plus Montelukast and Loratadine Plus Montelukast for Treatment of Moderate and Severe Persistent Allergic Rhinitis

Efficacy of combined therapy and maintenance treatment with intranasal glucocorticoid on allergic rhinitis

Clinical study on Bishushi Tablets combined with desloratadine citrate disodium in treatment of allergic rhinitis

Effect of loratadine on expression of T helper cell 17 in child-hood patients with allergic rhinitis

Acupuncture for Moderate to Severe Allergic Rhinitis: A Non-Randomized Controlled Trial.

Comparative of the treatment effects in adult moderate to severe allergic rhinitis by Loratadine with Budesonide nasal spray or Triamcinolone Acetonide nasal spray

Clinical study of prophylactic effect of budesonide on allergic rhinitis

Efficacy of Acupuncture on Moderate and Severe Allergic Rhinitis

Evaluation of efficiency and safety of combined loratadine and budesonide in patients with anaphylactic rhinitis

To Investigate the Effect of Pretreatment with Budesonide Spray in Patients with Allergic Rhinitis

A Systematic Review and Meta-Analysis of Loratadine Combined with Montelukast for the Treatment of Allergic Rhinitis

Comparison of the efficacy and mechanisms of intranasal budesonide, montelukast, and their combination in treatment of patients with seasonal allergic rhinitis

Efficacy of BCG Polysaccharide and Nucleic Acid Preparation on Allergic Rhinitis Patients

Effects of Oral Desloratadine Citrate Disodium Combined with Physiological Seawater Nasal Irrigation on IgE Levels, IL-4, IL-6, IL-13 and IFN-Î³ Expression and Treatment of Intermittent Allergic Rhinitis

The Efficacy of Upper and Lower Airway-Combined Therapy in Treating 103 Cases of Allergic Rhinitis

Effects of oral desloratadine citrate disodium combined with physiological seawater nasal irrigation on IgE levels, IL-4, IL-6, IL-13 and IFN-γ expression and treatment of intermittent allergic rhinitis

Efficacy and safety of beclometasone dipropionate aqueous nasal spray in the treatment of allergic rhinitis:a multicenter,randomized,double-blind,and controlled trial

Therapeutic effects investigation of physical therapy and pharmacotherapy in the treatment of persistent allergic rhinitis